Furthermore, FTO plays a major role in the development of T2DM, as m6A methyltransferases can inhibit adipogenesis, delay the onset and progression of obesity by inhibiting autophagosome formation, blocking mitotic clone expansion, and controlling adipogenic differentiation in mesenchymal stem cells (93). Here, FTO is linked to obesity due to melanocortin 4 receptor deficiency.